These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16563104)

  • 21. The diagnosis and management of chronic heart failure in the older patient.
    Gillespie ND
    Br Med Bull; 2005; 75-76():49-62. PubMed ID: 16495510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translating guidelines into clinical practice: benefits of an acute heart failure unit .
    Fonseca C; Ceia F; Sarmento PM; Marques F; Covas R; Aleixo A
    Rev Port Cardiol; 2007 Nov; 26(11):1111-28. PubMed ID: 18297836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.
    Nieminen MS; Brutsaert D; Dickstein K; Drexler H; Follath F; Harjola VP; Hochadel M; Komajda M; Lassus J; Lopez-Sendon JL; Ponikowski P; Tavazzi L; ;
    Eur Heart J; 2006 Nov; 27(22):2725-36. PubMed ID: 17000631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapeutic perspectives in heart failure]].
    Müller-Ehmsen J; Schwinger RH
    Z Arztl Fortbild Qualitatssich; 2003 Apr; 97(2):127-32. PubMed ID: 12806818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aspects of the Use of Angiotensin-Converting Enzyme Inhibitors and Calcium Antagonists in Treatment of Heart Failure in the Older Patient.
    Giles TD; Sander GE
    Am J Geriatr Cardiol; 1993 Jan; 2(1):51-54. PubMed ID: 11416283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of left ventricular diastolic heart failure: is it only blood pressure control?
    Koprowski A; Gruchala M; Rynkiewicz A
    Curr Opin Cardiol; 2009 Mar; 24(2):161-6. PubMed ID: 19532103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normalization of ejection fraction and resolution of symptoms in chronic severe heart failure is possible with modern medical therapy: clinical observations in 11 patients.
    Harinstein ME; Berliner JI; Shah SJ; Taegtmeyer H; Gheorghiade M
    Am J Ther; 2008; 15(3):206-13. PubMed ID: 18496257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute heart failure with preserved systolic function.
    Kumar R; Gandhi SK; Little WC
    Crit Care Med; 2008 Jan; 36(1 Suppl):S52-6. PubMed ID: 18158478
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managing congestive heart failure in a general hospital in Malaysia. Are we keeping pace with evidence?
    Chin SP; Sapari S; How SH; Sim KH
    Med J Malaysia; 2006 Aug; 61(3):278-83. PubMed ID: 17240575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Non invasive quantification of the parietal systolic stress of the left ventricle in patients with heart failure and its clinical application].
    Guadalajara Boo JF; González Zárate J; Bucio Reta E; Pérez P; Cué Carpio RJ
    Arch Cardiol Mex; 2007; 77(2):120-9. PubMed ID: 17715625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic heart failure treatment in the year 2006].
    De Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2006; 123(3):617-30. PubMed ID: 17451101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.
    Suşan M; Petrescu L; Riviş AI; Suşan RM; Burghină D; Dan R; Cozma D; Drăgulescu SI
    Rom J Intern Med; 2005; 43(3-4):187-98. PubMed ID: 16812979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-blocker therapy for patients with ventricular heart failure and reduced systolic function.
    Giles TD
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):18-29. PubMed ID: 19667666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trying to succeed when the right ventricle fails.
    McDonald MA; Ross HJ
    Curr Opin Cardiol; 2009 May; 24(3):239-45. PubMed ID: 19276973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acute and chronic heart failure].
    Stejfa M; Toman J; Spinarová L
    Vnitr Lek; 1997 Feb; 43(2):105-10. PubMed ID: 9245065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure.
    Kazi D; Deswal A
    Cardiol Clin; 2008 Feb; 26(1):1-14, v. PubMed ID: 18312901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.